Target- |
MechanismCell membrane function inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date22 Sep 1959 |
100 Clinical Results associated with Nikko Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Nikko Pharmaceutical Co., Ltd.
100 Deals associated with Nikko Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Nikko Pharmaceutical Co., Ltd.